Aurore Life Sciences is an API manufacturer based in India. It holds 35 active US drug master files and 27 valid CEPs. Customs aggregates show $10.3M of exports covering 143 molecules to 34 destinations in 2025.
| Site | FDA FEI |
|---|---|
| Sangareddy, India | 3018005839 |
| Hyderabad, India | Not on file |
| Molecule | Regulators | Docs |
|---|---|---|
| Levetiracetam | EDQM, US FDA | 4 |
| Celecoxib | EDQM, US FDA | 3 |
| Clozapine | EDQM, US FDA | 3 |
| Valaciclovir | EDQM, US FDA | 3 |
| Aciclovir | EDQM | 2 |
| Acyclovir | US FDA | 2 |
| Amlodipine | EDQM, US FDA | 2 |
| Dronedarone | EDQM, US FDA | 2 |
| Favipiravir | US FDA | 2 |
| Levothyroxine | EDQM, US FDA | 2 |
| Losartan | EDQM, US FDA | 2 |
| Oxcarbazepine | EDQM, US FDA | 2 |
| Raloxifene | EDQM, US FDA | 2 |
| Tafamidis | US FDA | 2 |
| Tolvaptan | US FDA | 2 |
| Valaciclovir Hydrochloride Hydrate | EDQM | 2 |
| Valganciclovir | EDQM, US FDA | 2 |
| Verapamil | EDQM, US FDA | 2 |
| Amlodipine Besilate | EDQM | 1 |
| Bilastine | US FDA | 1 |
| Dabigatran | US FDA | 1 |
| Dabigatran Etexilate Mesilate | EDQM | 1 |
| Desvenlafaxine | US FDA | 1 |
| Fesoterodine | US FDA | 1 |
| Flecainide | EDQM | 1 |
| Fluphenazine | US FDA | 1 |
| Indomethacin | US FDA | 1 |
| Levothyroxine Sodium | EDQM | 1 |
| Marbofloxacin | US FDA | 1 |
| Marbofloxacin For Veterinary Use | EDQM | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| CDSCO (India) | 3 | None |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2026 YTD | Not reported | $6.2M | 25 |
| 2025 | Not reported | $10.3M | 34 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. Aurore Life Sciences comes back tiered against every other supplier able to file there.
Start for free